Sage Therapeutics to Present at Upcoming September Investor Conferences
06 September 2023 - 8:30PM
Business Wire
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical
company leading the way to create a world with better brain health,
announced today that the Company will present at the following
upcoming investor conferences in September:
- Morgan Stanley 21st Annual Global
Healthcare Conference (New York, NY): fireside chat on
Wednesday, September 13, 2023 at 12:15 p.m. ET.
- TD Cowen 3rd Annual Novel Mechanisms in
Neuropsychiatry Summit (Virtual): fireside chat on
Wednesday, September 20, 2023 at 3:00 p.m. ET.
A live webcast of each event can be accessed on the Investor
page of Sage’s website at investor.sagerx.com. A replay of the
webcasts will be available following the completion of the event
and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly
leading the way to create a world with better brain health. Our
mission is to pioneer solutions to deliver life-changing brain
health medicines, so every person can thrive. For more information,
please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230906510555/en/
Investors Ashley Kaplowitz 786-252-1419
ashley.kaplowitz@sagerx.com
Media Contact Matthew Henson 917-930-7147
matthew.henson@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Oct 2023 to Oct 2024